Perceptive Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-225,758
Closed -$15M 107
2025
Q4
$15M Buy
+225,758
New +$14.6M 0.27% 72
2025
Q2
Sell
-178,000
Closed -$12.2M 93
2025
Q1
$12.2M Buy
+178,000
New +$14.5M 0.43% 47
2019
Q3
Sell
-240,000
Closed -$8.99M 113
2019
Q2
$8.99M Buy
+240,000
New +$7.54M 0.21% 67
2019
Q1
Sell
-14,932
Closed -$442K 112
2018
Q4
$442K Buy
+14,932
New +$474K 0.02% 90
2016
Q4
Sell
-715,396
Closed -$15.7M 197
2016
Q3
$15.7M Buy
715,396
+214,700
+43% +$4.78M 1.01% 23
2016
Q2
$9.93M Buy
500,696
+394,800
+373% +$6.72M 0.69% 34
2016
Q1
$1.8M Buy
+105,896
New +$1.77M 0.16% 88
2014
Q1
Sell
-120,000
Closed -$1.06M 134
2013
Q4
$1.06M Sell
120,000
-170,200
-59% -$1.35M 0.13% 64
2013
Q3
$2.05M Buy
+290,200
New +$1.84M 0.17% 60

Other funds holding DXCM

Perceptive Advisors's DXCM Position: Q1 2026 in Review

Perceptive Advisors sold out of DexCom (DXCM) in Q1 2026, closing a stake of 225,758 shares — an estimated $15M sold.

Perceptive Advisors first reported a position in DXCM in Q3 2013 and held it in 9 quarters. The position peaked at $15.7M in Q3 2016. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Perceptive Advisors reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Perceptive Advisors sold 225,758 DexCom shares in Q1 2026, an estimated $15M.
  • Perceptive Advisors first reported a position in DexCom in Q3 2013 and held it in 9 quarters.
  • Perceptive Advisors's DexCom position peaked at $15.7M in Q3 2016.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.